A nurse is teaching a client who has active pulmonary tuberculosis about management of medication for the disease. Which of the following statements is appropriate for the nurse to make?

A. Use a gravity flow set:
Incorrect Explanation: Using a gravity flow set is not appropriate for administering amphotericin B lipid complex.
Explanation: Amphotericin B lipid complex is typically administered using a dedicated infusion pump to ensure accurate control over the infusion rate and to prevent potential complications.
B. Discard the medication if it is yellow:
Incorrect Explanation: Discarding the medication solely based on its color may not be accurate for the amphotericin B lipid complex.
Explanation: Amphotericin B lipid complex may appear yellowish, and the color itself is not necessarily an indication of its potency or stability. It's important to follow specific guidelines provided by the pharmacy or manufacturer for assessing the integrity of the medication.
C. Prime the tubing with 0.9% sodium chloride:
Correct Answer: Priming the tubing with 0.9% sodium chloride is the appropriate action to ensure the medication is properly administered.
Explanation: Priming the tubing with a compatible solution, such as 0.9% sodium chloride, helps prevent the medication from adhering to the tubing and ensures that the full dose reaches the client.
D. Administer the medication over 2 hr:
Incorrect Explanation: Administering amphotericin B lipid complex over 2 hours is not the standard infusion time.
Explanation: Amphotericin B lipid complex is typically administered over a longer period, often 2-6 hours. However, the specific infusion rate and duration may vary based on the client's condition and the healthcare provider's orders.

A. Administer the medication into the client's muscles.
Explanation: This is incorrect because enoxaparin is usually administered subcutaneously, not into the muscle.
B. Apply firm pressure to the injection site following administration.
Explanation: This is incorrect because while applying gentle pressure after a subcutaneous injection is common practice, it is not specific to enoxaparin.
C. Insert the syringe needle halfway into the client's skin.
Explanation: This is incorrect because the needle should be inserted fully into the subcutaneous tissue, not just halfway, for proper administration of enoxaparin.
D. Expel the air bubble from the syringe prior to injection.
Explanation: This is the correct action. Expelling air bubbles from the syringe prior to injection helps ensure accurate dosing and prevents air from being injected into the subcutaneous tissue.
When administering enoxaparin (low molecular weight heparin) subcutaneously, it's important to expel any air bubbles from the syringe before injection. Air bubbles can cause discomfort and inaccuracies in dosage. The nurse should gently tap the syringe to move air bubbles to the top and then push the plunger slightly to expel the air. The other options are not correct procedures for administering enoxaparin. It is typically injected into the subcutaneous tissue, not a muscle, and firm pressure is not typically applied after administration. The needle is fully inserted into the skin, not halfway.